JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $243,000 | -35.0% | 35,700 | -1.9% | 0.00% | -25.0% |
| Q1 2021 | $374,000 | +175.0% | 36,400 | +87.6% | 0.00% | +100.0% |
| Q4 2020 | $136,000 | -14.5% | 19,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $159,000 | -77.2% | 19,400 | -80.8% | 0.00% | -80.0% |
| Q2 2020 | $697,000 | +45.2% | 100,900 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $480,000 | -45.3% | 100,900 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $878,000 | +157.5% | 100,900 | -1.5% | 0.01% | +125.0% |
| Q3 2019 | $341,000 | -32.7% | 102,400 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $507,000 | -22.0% | 102,400 | -2.2% | 0.01% | -28.6% |
| Q1 2019 | $650,000 | +12900.0% | 104,700 | +7378.6% | 0.01% | – |
| Q4 2018 | $5,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |